Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX vs REMIMAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELUGOLIX vs REMIMAZOLAM: Safety Overview

Metric RELUGOLIX REMIMAZOLAM
Total FAERS Reports 20,660 137
Deaths Reported 958 3
Death Rate 4.6% 2.2%
Hospitalizations 1,699 24
Average Patient Age 72.4 yrs 60.4 yrs
% Female Patients 1.4% 41.5%
FDA Approval Date Dec 18, 2020 Oct 6, 2020
Manufacturer Sumitomo Pharma America, Inc. Acacia Pharma, Ltd.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription